Structure-activity relationships of fluorene compounds inhibiting HCV variants - ScienceDirect
Velpatasvir - an overview | ScienceDirect Topics
Ribavirin: pharmacology, multiple modes of action and possible future perspectives | Future Virology
Antivirals for Hepatitis C | Concise Medical Knowledge
Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era
Amino Acid and Peptide‐Based Antiviral Agents - Skwarecki - 2021 - ChemMedChem - Wiley Online Library
Frontiers | Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report
Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection
Hepatitis C Virus Infection Treatment: Recent Advances and New Paradigms in the Treatment Strategies | IntechOpen
Sofosbuvir - Wikipedia
Sofosbuvir-Velpatasvir Epclusa - Treatment - Hepatitis C Online
Recent advances in managing chronic HCV... | F1000Research
Sofosbuvir - Wikipedia
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir | Scientific Reports
Advances in Treatment of Hepatitis C | IntechOpen
Hepatitis C Treatment in the Era of Direct-Acting Antiviral Agents: Challenges in Developing Countries - ScienceDirect
Cells | Free Full-Text | Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis
Cells | Free Full-Text | Hepatitis C Virus Infection: Host–Virus Interaction and Mechanisms of Viral Persistence
Epclusa, INN-sofosbuvir/velpatasvir
New perspectives for preventing hepatitis C virus liver graft infection - The Lancet Infectious Diseases
Evolution of efficacious pangenotypic hepatitis C virus therapies - Ashraf - 2019 - Medicinal Research Reviews - Wiley Online Library
Sofosbuvir: Arrival of a paradigm shift in the management of hepatitis C in India Singh K, Kamat S K, Shukla A - J Med Soc
Sofosbuvir/velpatasvir: A promising combination
